Related Experiment Video
Updated: Jul 19, 2026

08:08
Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Prostacyclin administration during cardiopulmonary bypass in man
Lancet (London, England)
|April 11, 1981
Abstract:
In a double-blind trial prostacyclin was given to 12 of 23 patients undergoing coronary vein grafting. The treatment group showed a preservation of platelet number and function, with a halving of blood loss in the first 18 h postoperatively. The heparin sparing effect of prostacyclin was confirmed, as were the vasodilator effects which were not troublesome.

